Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity
Author:
Affiliation:
1. Department of Dermatology Massachusetts General Hospital and Harvard Medical School Boston MA USA
2. Department of Medicine Division of Hematology and Oncology Massachusetts General Hospital Cancer Center and Harvard Medical School Boston MA USA
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20074
Reference58 articles.
1. Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-181 study.
2. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
3. Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
4. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
5. Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update;Journal for ImmunoTherapy of Cancer;2024-07
2. Association of Survival With Immune-Related Adverse Events—Time to Consider the Duration of Treatment—Reply;JAMA Dermatology;2024-03-01
3. Quality of Life Impact in Patients with Cutaneous Toxicities Caused by Epidermal Growth Factor Receptor Inhibitors and Immunotherapy;Dermatology;2024
4. Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis;Pharmaceuticals;2023-06-27
5. Updates in toxicities associated with immune checkpoint inhibitors;Expert Review of Clinical Immunology;2023-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3